ORAL INTAKE OF LOADING DOSES OF ANTIARRHYTHMIC DRUGS FOR SINUS RHYTHM RESTORATION IN ATRIAL FIBRILLATION

QR Code

ORAL INTAKE OF LOADING DOSES OF ANTIARRHYTHMIC DRUGS FOR SINUS RHYTHM RESTORATION IN ATRIAL FIBRILLATION

Oral intake of loading doses of antiarrhythmic drugs for sinus rhythm restoration in atrial fibrillation.

Saved in:

Bibliographic Details
Main Authors:	E. O. Khamitsayeva, P. K. Janashya, E. Y. Bogdanova, N. M. Shevchenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2003-06-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1755
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Methods of sinus rhythm restoration in patients with persistent and long-standing persistent atrial fibrillation
by: L. M. Kalmanson, et al.
Published: (2025-06-01)

THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY
by: T. Y. Gromyko, et al.
Published: (2016-06-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

Clinical Efficacy of Canrenone in Restoring Sinus Rhythm in Patients With Atrial Fibrillation—A Pilot, Randomized, Double-Blind Study
by: Rafał Dąbrowski MD, PhD, et al.
Published: (2025-07-01)

Stroke volume estimation by rheo-echocardiography during atrial fibrillation converted to sinus rhythm
by: Tadeusz PAŁKO, et al.
Published: (2015-07-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
by: I. G. Fomina, et al.
Published: (2005-04-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation (part II)
by: I. G. Fomina, et al.
Published: (2005-10-01)

Propafenone and lisinopril therapy effectiveness for sinus rhythm maintenance in patients with persistent atrial fibrillation and arterial hypertension (PROMETEY-III)
by: R. G. Oganov, et al.
Published: (1970-01-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

Three-Dimensional Left Atrial Reservoir Function During Sinus Rhythm Can Discriminate Between a History of Paroxysmal Atrial Fibrillation and its Absence
by: Jiří Plášek, et al.
Published: (2025-06-01)

SINUS NODE DYSFUNCTIONS AND FEATURES OF NORMAL RHYTHM RESTORATION AFTER HEART TRANSPLANTATION
by: S.Y. Shemakin
Published: (2009-05-01)

ANTIARRHYTHMIC THERAPY EFFECTIVENESS AND IMPACT ON LEFT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: O. N. Miller, et al.
Published: (2011-08-01)

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO
by: R. D. Kurbanov, et al.
Published: (2020-12-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Prediction of sinus rhythm maintenance after radiofrequency ablation in patients with atrial fibrillation using speckle tracking echocardiography and dynamics of left atrial structural and functional parameters
by: T. I. Musin, et al.
Published: (2021-07-01)

Hearing the Vagus Nerve’s Rhythm in Patients with Paroxysmal Atrial Fibrillation
by: A. A. Nechepurenko, et al.
Published: (2020-07-01)

Differentiated approach to rhythm conversion in patients with atrial fibrillation and flutter
by: A. G. Pronin, et al.
Published: (2021-12-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
by: A. G. Pronin, et al.
Published: (2020-12-01)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
by: Konstantinos Grigoriou, et al.
Published: (2025-07-01)

CORRELATION BETWEEN HEART RHYTHM AND SYMPTOMS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AFTER CATHETER ABLATION AND ANTIARRHYTHMIC THERAPY BASED ON DATA OBTAINED FROM IMPLANTABLE CARDIAC MONITORS
by: A. A. Simonyan, et al.
Published: (2016-09-01)

Mechanisms of paroxysmal atrial fibrillation in patients with sick sinus syndrome
by: S. Yu. Ivanov, et al.
Published: (2004-08-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

Catheter ablation of atrial fibrillation versus antiarrhythmic therapy in patients with left ventricular systolic dysfunction
by: D. F. Ardus, et al.
Published: (2023-05-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Rhythmocardiography in the analysis of sinus rhythm wave variability
by: T. F. Mironova, et al.
Published: (2007-10-01)

INFLUENCE OF AEROBIC AND RESISTANT LOAD ON THE RISK OF ATRIAL FIBRILLATION IN ARTERIAL HYPERTENSION AND PAROXYSMAL ATRIAL FIBRILLATION
by: K. G. Adamyan, et al.
Published: (2015-10-01)

Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective
by: Yaariv Khaykin, et al.
Published: (2016-10-01)

Association of Rate‐Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation
by: Benjamin Lidgard, et al.
Published: (2025-06-01)

Clinical outcomes of direct oral anticoagulant off-label dosing in nonvalvular atrial fibrillation
by: M. Jansson, et al.
Published: (2025-09-01)

INFLUENCE OF antiarrhythmic THERAPY ON DIASTOLIC FUNCTION OF THE LEFT VENTRICULAR MYOCARDIUM and QUALITY OF LIFE in PATIENTS WITH HYPERTENSION COMPLICATED BY PAROXySMAL atrial FIBRILLATION
by: I. S. Dik, et al.
Published: (2019-02-01)

Early Rhythm Control of Atrial Fibrillation in Cancer Survivors: A Nationwide Population‐Based Study
by: Seokmoon Han, et al.
Published: (2025-07-01)